IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 123 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,511,542 | +2.0% | 424,017 | +0.8% | 0.42% | +9.5% |
| Q1 2023 | $4,424,891 | -15.1% | 420,617 | 0.0% | 0.38% | -13.9% |
| Q4 2022 | $5,211,445 | +20.1% | 420,617 | +0.4% | 0.44% | +12.2% |
| Q3 2022 | $4,340,000 | +12.5% | 418,917 | +25.2% | 0.39% | +26.9% |
| Q2 2022 | $3,857,000 | -8.9% | 334,517 | -0.6% | 0.31% | +12.8% |
| Q1 2022 | $4,234,000 | +6.9% | 336,517 | -0.9% | 0.27% | +3.4% |
| Q4 2021 | $3,961,000 | -11.0% | 339,617 | -0.3% | 0.26% | -22.7% |
| Q3 2021 | $4,449,000 | +14.2% | 340,617 | +12.6% | 0.34% | +10.6% |
| Q2 2021 | $3,895,000 | +15.1% | 302,617 | 0.0% | 0.31% | +9.5% |
| Q1 2021 | $3,383,000 | +7254.3% | 302,617 | +6478.6% | 0.28% | +1786.7% |
| Q2 2013 | $46,000 | – | 4,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |